Novel workflow for combining Raman spectroscopy and MALDI-MSI for tissue based studies.
Thomas Bocklitz1, Katharina Bräutigam2, Annett Urbanek3
1Institute of Physical Chemistry and Abbe Center of Photonics, University of Jena, Helmholtzweg 4, 07743, Jena, Germany. thomas.bocklitz@uni-jena.de.
Analytical and Bioanalytical Chemistry
|September 17, 2015
Summary
This study introduces a computational workflow to combine Raman spectroscopy and MALDI-MS imaging for cancer research. This multimodal approach enhances tumor characterization, improving diagnosis and treatment strategies.
Area of Science:
- Biomedical Engineering
- Analytical Chemistry
- Oncology
Background:
- Molecular cancer heterogeneity poses significant challenges for accurate tumor diagnosis and effective treatment.
- Multidisciplinary approaches combining various analytical techniques are crucial for comprehensive tumor analysis and multimodal imaging.
Purpose of the Study:
- To develop a computational workflow for integrating matrix-assisted laser desorption/ionization mass spectrometric (MALDI-MS) imaging and Raman microspectroscopic imaging.
- To validate the utility of this workflow in confirming spectral histopathology (SHP) findings between the two techniques.
- To demonstrate the combined approach's capability in characterizing tissue types, metabolic states, and epithelial differentiation in cancer samples.
Main Methods:
- Development of a computational workflow to fuse data from MALDI-MS imaging and Raman microspectroscopic imaging.
- Application of the workflow to a larynx carcinoma tissue sample.
- Cross-validation of spectral histopathology (SHP) derived from Raman spectroscopy using MALDI-MS imaging data.
Main Results:
- Successful integration of MALDI-MS imaging and Raman microspectroscopic imaging data through a computational workflow.
- Confirmation of Raman spectroscopic-based SHP using MALDI-imaging.
- Identification of distinct tissue types and metabolic states within the larynx carcinoma sample using Raman spectra.
- Enhanced characterization of epithelial differentiation and dysplastic alterations through combined MALDI spectra analysis.
Conclusions:
- The developed computational workflow effectively integrates MALDI-MS imaging and Raman microspectroscopic imaging for advanced cancer tissue analysis.
- This multimodal imaging approach provides a more comprehensive understanding of tumor molecular heterogeneity, metabolic states, and differentiation.
- The findings support the potential of this combined technique for improving cancer diagnosis and guiding treatment strategies.
Related Concept Videos
01:19MALDI-TOF Mass Spectrometry
7.6K
Mass spectrometry is a powerful characterization technique that can identify and separate a wide variety of compounds ranging from chemical to biological entities, based on their mass-to-charge ratio (m/z). The instruments that allow this detection, known as mass spectrometers, have three components: an ion source, a mass analyzer, and a detector. These spectrometers differ based on the nature of their ion source and analyzers.Matrix-assisted laser desorption ionization (MALDI) is a commonly...
7.6K
01:33Peptide Identification Using Tandem Mass Spectrometry
8.8K
Tandem mass spectrometry, also known as MS/MS or MS2, is an analytical technique that employs two mass analyzers. Essentially it is a series of mass spectrometers that helps isolate a particular biomolecule and then helps study its chemical properties.
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
8.8K